Why is Secretary of State Marco Rubio allowing a crank who spews CCP propaganda to serve as a senior diplomat?
Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...
Bristol Myers Squibb clocked $10 million in sales for new schizophrenia drug Cobenfy in the fourth quarter of 2024, with the ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive ...
We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks.
When it comes to the potential of H5N1 avian flu, otherwise known as bird flu, picking up mutations that may lead to human-to ...
Dr. Raheja has expanded psychiatric care through telepsychiatry, bringing services to rural Wisconsin at Thedacare Regional ...
Doctors treating Valdo Calocane, who was diagnosed with paranoid schizophrenia and murdered two university students and a school caretaker, refrained from giving him long lasting depot injections of ...
Target 7 breaks down a series of case dismissals due to competency and the extensive costs it can have on law enforcement.
Kids and teens can also get migraines, but Black and Hispanic children seen in emergency rooms are more likely to have their condition go undiagnosed, new research shows.
Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results